How to Install and Uninstall texlive-lexref.noarch Package on Fedora 38
Last updated: October 04,2024
1. Install "texlive-lexref.noarch" package
This guide covers the steps necessary to install texlive-lexref.noarch on Fedora 38
$
sudo dnf update
Copied
$
sudo dnf install
texlive-lexref.noarch
Copied
2. Uninstall "texlive-lexref.noarch" package
This is a short guide on how to uninstall texlive-lexref.noarch on Fedora 38:
$
sudo dnf remove
texlive-lexref.noarch
Copied
$
sudo dnf autoremove
Copied
3. Information about the texlive-lexref.noarch package on Fedora 38
Last metadata expiration check: 4:50:40 ago on Sat Mar 16 22:59:57 2024.
Available Packages
Name : texlive-lexref
Epoch : 10
Version : svn36026.1.1a
Release : 65.fc38
Architecture : noarch
Size : 21 k
Source : texlive-2022-65.fc38.src.rpm
Repository : fedora
Summary : Convenient and uniform references to legal provisions
URL : http://tug.org/texlive/
License : LPPL-1.3c
Description : The package is aimed at continental lawyers (especially those
: in Switzerland and Germany), allowing the user to make
: references to legal provisions conveniently and uniformly. The
: package also allows the user to add cited Acts to a
: nomenclature list (automatically), and to build specific
: indexes for each cited Act. The package is still under
: development, and should be treated as an 'alpha'-release.
Available Packages
Name : texlive-lexref
Epoch : 10
Version : svn36026.1.1a
Release : 65.fc38
Architecture : noarch
Size : 21 k
Source : texlive-2022-65.fc38.src.rpm
Repository : fedora
Summary : Convenient and uniform references to legal provisions
URL : http://tug.org/texlive/
License : LPPL-1.3c
Description : The package is aimed at continental lawyers (especially those
: in Switzerland and Germany), allowing the user to make
: references to legal provisions conveniently and uniformly. The
: package also allows the user to add cited Acts to a
: nomenclature list (automatically), and to build specific
: indexes for each cited Act. The package is still under
: development, and should be treated as an 'alpha'-release.